Authors: Mavroudis, D Papadakis, E Veslemes, M Tsiafaki, X Stavrakakis, J Kouroussis, C Kakolyris, S Bania, E Jordanoglou, J Agelidou, M Vlachonicolis, J Georgoulias, V

Citation: D. Mavroudis et al., A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer, ANN ONCOL, 12(4), 2001, pp. 463-470

Authors: Kakolyris, S Papadakis, E Tsiafaki, X Kalofonos, C Rapti, A Toubis, M Bania, E Kouroussis, C Chainis, K Androulakis, N Agelaki, S Sarra, E Vardakis, N Georgoulias, V

Citation: S. Kakolyris et al., Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study, LUNG CANC, 32(2), 2001, pp. 179-187

Authors: Georgoulias, V Papadakis, E Alexopoulos, A Tsiafaki, X Rapti, A Veslemes, M Palamidas, P Vlachonikolis, I

Citation: V. Georgoulias et al., Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial, LANCET, 357(9267), 2001, pp. 1478-1484

Authors: Agelaki, S Bania, H Kouroussis, C Blazoyiannakis, G Sougalkos, J Tsiafaki, X Harpidou, A Kalbakis, K Rapti, A Androulakis, N Sarra, E Georgoulias, V Papadakis, E

Citation: S. Agelaki et al., Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: Two parallel multicenter phase II trials, ONCOL-BASEL, 60(3), 2001, pp. 235-241